|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y,
Ueda J, Wei W, Inoue M and Tanaka H: Epidemiology of esophageal
cancer in Japan and China. J Epidemiol. 23:233–242. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eastman A: The Mechanism of Action of
Cisplatin: From Adducts to Apoptosis. Cisplatin Verlag Helvetica
Chimica Acta. 111–134. 2006.
|
|
5
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Czabotar PE, Lessene G, Strasser A and
Adams JM: Control of apoptosis by the BCL-2 protein family:
Implications for physiology and therapy. Nat Rev Mol Cell Biol.
15:49–63. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marani M, Tenev T, Hancock D, Downward J
and Lemoine NR: Identification of novel isoforms of the bh3 domain
protein bim which directly activate bax to trigger apoptosis. Mol
Cell Biol. 22:3577–3589. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Connor L, Strasser A, O'Reilly LA,
Hausmann G, Adams JM, Cory S and Huang DC: Bim: A novel member of
the Bcl-2 family that promotes apoptosis. EMBO J. 17:384–395. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O'Reilly LA, Cullen L, Visvader J,
Lindeman GJ, Print C, Bath ML, Huang DC and Strasser A: The
Proapoptotic BH3-only protein bim is expressed in hematopoietic,
epithelial, neuronal, and germ cells. Am J Pathol. 157:449–461.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu Y, Sato F, Yamada T, Bhawal UK,
Kawamoto T, Fujimoto K, Noshiro M, Seino H, Morohashi S, Hakamada
K, et al: The BHLH transcription factor DEC1 plays an important
role in the epithelial-mesenchymal transition of pancreatic cancer.
Int J Oncol. 41:1337–1346. 2012.PubMed/NCBI
|
|
11
|
Honma S, Kawamoto T, Takagi Y, Fujimoto K,
Sato F, Noshiro M, Kato Y and Honma K: Dec1 and Dec2 are regulators
of the mammalian molecular clock. Nature. 419:841–844. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyazaki K, Kawamoto T, Tanimoto K,
Nishiyama M, Honda H and Kato Y: Identification of functional
hypoxia response elements in the promoter region of the DEC1 and
DEC2 genes. J Biol Chem. 277:47014–47021. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu Y, Sato F, Bhawal UK, Kawamoto T,
Fujimoto K, Noshiro M, Morohashi S, Kato Y and Kijima H: Basic
helix-loop-helix transcription factors DEC1 and DEC2 regulate the
paclitaxel-induced apoptotic pathway of MCF-7 human breast cancer
cells. Int J Mol Med. 27:491–495. 2011.PubMed/NCBI
|
|
14
|
Wu Y, Sato F, Bhawal UK, Kawamoto T,
Fujimoto K, Noshiro M, Seino H, Morohashi S, Kato Y and Kijima H:
BHLH transcription factor DEC2 regulates pro-apoptotic factor Bim
in human oral cancer HSC-3 cells. Biomed Res. 33:75–82. 2011.
View Article : Google Scholar
|
|
15
|
Liu Y, Sato F, Kawamoto T, Fujimoto K,
Morohashi S, Akasaka H, Kondo J, Wu Y, Noshiro M, Kato Y and Kijima
H: Anti-apoptotic effect of the basic helix-loop-helix (bHLH)
transcription factor DEC2 in human breast cancer cells. Genes
Cells. 15:315–325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Y, Sato H, Suzuki T, Yoshizawa T,
Morohashi S, Seino H, Kawamoto T, Fujimoto K, Kato Y and Kijima H:
Involvement of c-Myc in the proliferation of MCF-7 human breast
cancer cells induced by bHLH transcription factor DEC2. Int J Mol
Med. 35:815–820. 2015.PubMed/NCBI
|
|
17
|
Sato F, Bhawal UK, Kawamoto T, Fujimoto K,
Imaizumi T, Imanaka T, Kondo J, Koyanagi S, Noshiro M, Yoshida H,
et al: Basic-helix-loop-helix (bHLH) transcription factor DEC2
negatively regulates vascular endothelial growth factor expression.
Genes Cells. 13:131–144. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sorensen DN, Dakup PP and Gaddameedhi S:
Chronopharmacology of cisplatin: Role of the circadian rhythm in
modulating the cisplatin transporters levels. The FASEB Journal.
30:(1 Suppl). S9352016.
|
